The Valley Desk

NCT00093626 · Interventional trial

Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer

Overall registry status Completed

Phase 2

Conditions Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov